Skip to Content
Merck
  • Novel compound heterozygous mutation in WEE2 is associated with fertilization failure: case report of an infertile woman and literature review.

Novel compound heterozygous mutation in WEE2 is associated with fertilization failure: case report of an infertile woman and literature review.

BMC women's health (2020-11-06)
Ye Tian, Guojie Wang, Jin Wang, Xiaohuan Mu, Haixia Chen, Xueru Song, Xiaohong Bai
ABSTRACT

Fertilization failure after intracytoplasmic sperm injection continues to affect couples and the etiology is not well-understood. We characterized a couple with 2-year history of primary unexplained infertility. Three different assisted reproduction attempts (IVF + rescue ICSI, ICSI and ICSI-AOA) showed repeated fertilization failure for MII oocyte retrieval after controlled ovarian hyperstimulation. After whole-exome sequencing and sanger sequencing of the couple and their family members, variant pathogenicity was assessed using SIFT, PolyPhen2, Mutation Taster, and Human Splicing Finder software. We identified novel compound heterozygous mutations, c.1535 + 3A > G and c.946C > T (p. Leu316Phe), in WEE2 in the female proband. Trios analysis of the variations revealed an autosomal recessive pattern. c.1535 + 3A > G in WEE2 was predicted to break the wild-type donor site and affect splicing, and the missense mutation c.946C > T (p. Leu316Phe) of WEE2 was predicted to be pathogenic. A novel compound heterozygous mutation in WEE2 was identified in an infertile female who experienced repeated fertilization failure even after ICSI-AOA. These novel mutations in WEE2 provided genetic evidence for fertilization failure.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ionomycin from Streptomyces conglobatus, ≥98% (HPLC)